NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 37532)

Published in Proc Natl Acad Sci U S A on July 10, 2001


S Fiorucci1, E Antonelli, O Morelli, A Mencarelli, A Casini, T Mello, B Palazzetti, D Tallet, P del Soldato, A Morelli

Author Affiliations

1: Clinica di Gastroenterologia ed Epatologia, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Perugia, 06122 Perugia, Italy.

Articles citing this

Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology (2008) 1.41

Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol (2008) 1.17

Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis. Int J Exp Pathol (2008) 0.95

Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol (2013) 0.92

Retracted Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Br J Pharmacol (2004) 0.90

Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. World J Gastroenterol (2009) 0.87

Acetaminophen hepatotoxicity: NO to the rescue. Br J Pharmacol (2004) 0.86

Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol (2006) 0.79

U12, a UDCA derivative, acts as an anti-hepatoma drug lead and inhibits the mTOR/S6K1 and cyclin/CDK complex pathways. PLoS One (2014) 0.77

Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis. F1000Res (2016) 0.76

AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression. PLoS One (2016) 0.76

Future therapy of portal hypertension in liver cirrhosis - a guess. F1000Prime Rep (2014) 0.75

Expression of concern. Proc Natl Acad Sci U S A (2008) 0.75

NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA. Int J Hepatol (2011) 0.75

Articles cited by this

Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (1991) 8.41

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med (1993) 5.97

Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol (1990) 5.14

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A (1985) 4.76

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology (1995) 2.30

Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res (1999) 2.26

Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest (1992) 1.71

Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology (1998) 1.68

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology (1996) 1.66

Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest (1993) 1.63

Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology (1999) 1.58

Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest (1995) 1.55

Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest (1993) 1.54

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology (1998) 1.47

Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol (1994) 1.44

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology (1996) 1.42

Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A (1993) 1.38

Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology (1993) 1.35

A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol (1994) 1.28

Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. Gastroenterology (2000) 1.15

An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14

NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13

Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest (2000) 1.06

Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03

Pharmacological treatment of portal hypertension: present and future. J Hepatol (1998) 1.00

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med (1991) 0.93

Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest (1995) 0.92

The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology (1998) 0.90

Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties. Br J Pharmacol (1996) 0.88

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension. J Hepatol (1990) 0.85

Organic nitrates in portal hypertension. Am J Gastroenterol (1994) 0.78

Articles by these authors

Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84

High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res (1998) 3.56

Job strain in relation to body mass index: pooled analysis of 160 000 adults from 13 cohort studies. J Intern Med (2011) 3.14

The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell (1993) 2.96

Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene (1991) 2.86

Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75

Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol (1999) 2.66

Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J (1992) 2.14

Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med (2010) 2.04

Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus. Proc Natl Acad Sci U S A (1991) 1.90

Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology (1999) 1.88

Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the 'Florence' diet is not Mediterranean. Eur J Clin Nutr (2005) 1.85

Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84

Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology (1996) 1.83

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A (2001) 1.76

Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest (1992) 1.71

Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69

Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology (2000) 1.67

Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64

Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol (1994) 1.64

Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene (1992) 1.59

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther (2006) 1.58

Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology (1992) 1.58

Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. Gastroenterology (2001) 1.57

Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology (1998) 1.55

Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun (1993) 1.51

Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48

Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med (1990) 1.47

Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol (1994) 1.46

Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45

Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol (2007) 1.45

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43

Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol (1990) 1.41

Blood alcohol levels after prolonged histamine-2-receptor antagonist treatment. Ann Intern Med (1994) 1.39

Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39

S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology (1990) 1.39

Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38

Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37

Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36

The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut (2005) 1.29

Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29

Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27

Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24

Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1992) 1.24

Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med (2010) 1.24

Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22

Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology (1997) 1.22

Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res (2000) 1.19

Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem (1989) 1.18

Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16

An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14

IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14

Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13

NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13

Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13

Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology (1990) 1.12

Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut (2004) 1.12

Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol (1996) 1.11

Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med (1999) 1.10

Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil (2008) 1.10

Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10

Cervical intraepithelial neoplasia III. An estimate of screening error rates and optimal screening interval. Acta Cytol (1985) 1.09

Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum (1997) 1.09

Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09

Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07

Gynecomastia during omeprazole therapy. N Engl J Med (1991) 1.07

The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06

Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05

A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol (2000) 1.05

Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth (2009) 1.03

Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes (1994) 1.03

Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03

Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03

Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. Hepatology (1999) 1.01

Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes. Eur J Immunol (1998) 1.01

Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00

Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00

False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics (1994) 1.00

Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00

Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. Mini Rev Med Chem (2011) 0.99

Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99

GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99

Mechanisms of cell injury in the killing of cultured hepatocytes by bromobenzene. J Biol Chem (1982) 0.99

D-dimer levels during delivery and the postpartum. J Thromb Haemost (2005) 0.99

Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene (1998) 0.99

Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98

Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans. J Immunol (1999) 0.98

Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol (1989) 0.98